secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2026-06-10T22:39:35+00:00
Accession:  0001372514-26-000059
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora shareholders approve 1.5M share increase to 2024 equity incentive plan
----------------------------------------------------------------------------

- Stockholders approved amendment to 2024 Equity Incentive Plan, increasing authorized shares by 1,500,000.
- Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle re-elected as Class II directors with >1M votes for each.
- Non-binding advisory vote on executive compensation approved: 1,019,325 for, 21,670 against.
- Ratification of Haskell & White LLP as auditor for FY 2026: 2,358,943 for, 5,403 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251426000059/0001372514-26-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251426000059/kprx-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001372514-26-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer